GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Total Inventories

IQMDU (Intelligent Medicine Acquisition) Total Inventories : $0.00 Mil (As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition Total Inventories?

Intelligent Medicine Acquisition's total inventories for the quarter that ended in Dec. 2022 was $0.00 Mil. Intelligent Medicine Acquisition's average total inventories from the quarter that ended in Sep. 2022 to the quarter that ended in Dec. 2022 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Intelligent Medicine Acquisition's Net-Net Working Capital per share for the quarter that ended in Dec. 2022 was $-0.45.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Intelligent Medicine Acquisition Total Inventories Historical Data

The historical data trend for Intelligent Medicine Acquisition's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Medicine Acquisition Total Inventories Chart

Intelligent Medicine Acquisition Annual Data
Trend Dec21 Dec22
Total Inventories
- -

Intelligent Medicine Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22
Total Inventories Get a 7-Day Free Trial - - - - -

Intelligent Medicine Acquisition Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Intelligent Medicine Acquisition  (NAS:IQMDU) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Intelligent Medicine Acquisition's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2022 is

Net-Net Working Capital Per Share (Q: Dec. 2022 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.05+0.75 * 0+0.5 * 0-11.635
-0-0)/25.875
=-0.45

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Intelligent Medicine Acquisition's Days Inventory for the three months ended in Dec. 2022 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2022 )/Cost of Goods Sold (Q: Dec. 2022 )*Days in Period
=0/0*365 / 4
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Intelligent Medicine Acquisition's Inventory Turnover for the quarter that ended in Dec. 2022 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2022 ) / Average Total Inventories (Q: Dec. 2022 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Intelligent Medicine Acquisition's Inventory to Revenue for the quarter that ended in Dec. 2022 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2022 ) / Revenue (Q: Dec. 2022 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Intelligent Medicine Acquisition Total Inventories Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelligent Medicine Acquisition Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Total Inventories
Comparable Companies
IFIN WAVC FRW SHCA AVAC OCA ISLE BIOT DWIN TRCA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
9001 Burdette Road, Bethesda, MD, USA, 20817
Website
https://iqmdspac.com
Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken director 2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary director 3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon director, officer: CEO and CFO 9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball director 9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc 10 percent owner 9001 BURDETTE ROAD, BETHESDA MD 20817